Prostate Cancer - Results from #23000

Management of biochemical recurrence after primary treatment of prostate cancer: A systematic review of the literature - Abstract July 12, 2013

Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer - Abstract July 11, 2013

Successful treatment with docetaxel and prednisolone for paxlitaxel and carboplatin-resistant prostate cancer - Abstract July 11, 2013

Transrectal electrical impedance tomography of the prostate: Spatially coregistered pathological findings for prostate cancer detection - Abstract July 11, 2013

Development of the Men's Prostate Awareness Church Training: Church-based workshops for African American men - Abstract July 11, 2013

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome - Abstract July 11, 2013

Tumor volume adds prognostic value in patients with organ-confined prostate cancer - Abstract July 11, 2013

Influence of plasmatic testosterone during natural history of prostate cancer: A review - Abstract July 11, 2013

Method for data analysis in different institutions: Example of image guidance of prostate cancer patients - Abstract July 11, 2013

Incidence of prostate cancer after termination of screening in a population-based randomised screening trial - Abstract July 11, 2013

National evidence on the use of shared decision making in prostate-specific antigen screening - Abstract July 11, 2013

Understanding variation in the quality of the surgical treatment of prostate cancer - Abstract July 11, 2013

Image visibility of cancer to enhance targeting precision and spatial mapping biopsy for focal therapy of prostate cancer - Abstract July 11, 2013

Transperineal template-guided saturation biopsy using a modified technique: Outcome of 270 cases requiring repeat prostate biopsy - Abstract July 10, 2013

The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II) - A survey among Italian radiation oncologists on radical radiotherapy in prostate cancer - Abstract July 10, 2013

Racial differences in time from prostate cancer diagnosis to treatment initiation: A population-based study - Abstract July 10, 2013

Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer - Abstract July 10, 2013

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: A cost-effectiveness analysis - Abstract July 10, 2013

Urologists applaud members of Congress for their strong support for preserving the in-office ancillary services exception (IOASE) July 10, 2013

Androgen deprivation for prostate cancer - Abstract July 10, 2013

Page 1151 of 1447